v3.26.1
Goodwill and Other Intangible Assets (Tables)
 12 Months Ended
Jun. 30, 2026
Intangible Asset, Goodwill and Other [Abstract]  
Schedule of Goodwill by Reportable Segment
The following table summarizes the changes in the carrying amount of goodwill for the two reportable segments and the remaining operating segments, included in Other and in total:
(in millions)
Pharmaceutical and Specialty Solutions (1)
Global Medical Products and Distribution (2)
Other
(3) (4)
Total
Balance at June 30, 2024$3,555 — $1,170 $4,725 
Goodwill acquired, net of purchase price adjustments4,389 — 578 4,967 
Foreign currency translation adjustments and other(1)— — (1)
Balance at June 30, 2025$7,943 $— $1,748 $9,691 
Goodwill acquired, net of purchase price adjustments1,936 — (1)1,935 
Foreign currency translation adjustments and other— — — — 
Goodwill Impairment(184)— — (184)
Balance at June 30, 2026$9,695 $— $1,747 $11,442 
(1)    At June 30, 2026, the Pharma segment accumulated goodwill impairment loss was $184 million related to the Navista & ION reporting unit.
(2)    At June 30, 2026 and 2025, the GMPD segment accumulated goodwill impairment loss was $5.4 billion.
(3)    Comprised of the remaining operating segments, Nuclear and Precision Health Solutions, at-Home Solutions, and OptiFreight® Logistics.
(4)    At June 30, 2026 and 2025, the Nuclear and Precision Health Solutions accumulated goodwill impairment loss was $829 million.

Goodwill increased in fiscal 2026 primarily due to the acquisition of Solaris Health within the Pharma segment. Goodwill recognized in connection with the acquisition primarily represents the anticipated
benefits from the expected growth from new customers, the assembled workforce of the acquired entities and synergies of integrating these businesses. Substantially all of the goodwill recorded is expected to be non-deductible for income tax purposes.
We performed interim quantitative goodwill impairment testing for the Navista & ION reporting unit during the three months ended March 31, 2026, which resulted in pre-tax impairment charges of $184 million. The impairment charge was primarily due to changes in the risk profile of the business plans, resulting in an increase in the discount rate. These changes reflect business model updates and base operational performance.
We performed interim quantitative goodwill impairment testing for GMPD during fiscal 2024, which resulted in pre-tax goodwill impairment charges of $675 million, which was included in impairments and (gain)/loss on disposal of assets, net in our consolidated statements of earnings. GMPD had no goodwill balance remaining as of March 31, 2024.
Other Intangible Assets
The following tables summarize other intangible assets by class at June 30:
2026
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible		Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles:
Trademarks and patents$24 $— $24 N/A
Total indefinite-life intangibles24 — 24 N/A
Definite-life intangibles:
Customer intangibles
3,625 2,814 811 9
Trademarks, trade names, and patents
1,583 558 1,025 8
Developed technology and other1,030 779 251 5
Non-Competition Agreements111 33 78 4
Total definite-life intangibles6,349 4,184 2,165 8
Total other intangible assets$6,373 $4,184 $2,189 N/A
2025
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible
Indefinite-life intangibles:
Trademarks and patents$13 $— $13 
Total indefinite-life intangibles13 — 13 
Definite-life intangibles:
Customer intangibles
3,876 2,639 1,237 
Trademarks, trade names, and patents
1,340 459 881 
Developed technology and other1,030 726 304 
Non-Competition Agreements72 21 51 
Total definite-life intangibles6,318 3,845 2,473 
Total other intangible assets$6,331 $3,845 $2,486 
The increase in gross definite-life intangibles is primarily due to the Solaris acquisition. Total amortization of intangible assets was $361 million, $303 million, and $264 million for fiscal 2026, 2025, and 2024, respectively.
The following table summarizes the estimated annual amortization for intangible assets for fiscal 2027 through fiscal 2031:
(in millions)
Estimated Amortization Expense
2027$384 
2028349 
2029327 
2030306 
2031253 
Intangible Asset, Finite-Lived
The following tables summarize other intangible assets by class at June 30:
2026
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible		Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles:
Trademarks and patents$24 $— $24 N/A
Total indefinite-life intangibles24 — 24 N/A
Definite-life intangibles:
Customer intangibles
3,625 2,814 811 9
Trademarks, trade names, and patents
1,583 558 1,025 8
Developed technology and other1,030 779 251 5
Non-Competition Agreements111 33 78 4
Total definite-life intangibles6,349 4,184 2,165 8
Total other intangible assets$6,373 $4,184 $2,189 N/A
2025
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible
Indefinite-life intangibles:
Trademarks and patents$13 $— $13 
Total indefinite-life intangibles13 — 13 
Definite-life intangibles:
Customer intangibles
3,876 2,639 1,237 
Trademarks, trade names, and patents
1,340 459 881 
Developed technology and other1,030 726 304 
Non-Competition Agreements72 21 51 
Total definite-life intangibles6,318 3,845 2,473 
Total other intangible assets$6,331 $3,845 $2,486 
Intangible Asset, Indefinite-Lived
The following tables summarize other intangible assets by class at June 30:
2026
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible		Weighted- Average Remaining Amortization Period (Years)
Indefinite-life intangibles:
Trademarks and patents$24 $— $24 N/A
Total indefinite-life intangibles24 — 24 N/A
Definite-life intangibles:
Customer intangibles
3,625 2,814 811 9
Trademarks, trade names, and patents
1,583 558 1,025 8
Developed technology and other1,030 779 251 5
Non-Competition Agreements111 33 78 4
Total definite-life intangibles6,349 4,184 2,165 8
Total other intangible assets$6,373 $4,184 $2,189 N/A
2025
(in millions)Gross
Intangible		Accumulated
Amortization		Net
Intangible
Indefinite-life intangibles:
Trademarks and patents$13 $— $13 
Total indefinite-life intangibles13 — 13 
Definite-life intangibles:
Customer intangibles
3,876 2,639 1,237 
Trademarks, trade names, and patents
1,340 459 881 
Developed technology and other1,030 726 304 
Non-Competition Agreements72 21 51 
Total definite-life intangibles6,318 3,845 2,473 
Total other intangible assets$6,331 $3,845 $2,486 
Intangible Asset, Finite-Lived, and Capitalized Cost, Software to be Sold, Leased, or Marketed, Estimated Amortization Expense
The following table summarizes the estimated annual amortization for intangible assets for fiscal 2027 through fiscal 2031:
(in millions)
Estimated Amortization Expense
2027$384 
2028349 
2029327 
2030306 
2031253